CLASS II Drug recall · Reported 1 Apr 2015 · FDA Enforcement Report

Hydroxocobalamin Injection Solution 1 mg/mL Inj., Rx recalled

American Specialty Pharmacy is recalling Hydroxocobalamin Injection Solution 1 mg/mL Inj., Rx, compounded by American Specialty, distributed in Texas. The recall was initiated on 12 Dec 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot# 10082014@10
Quantity recalled15 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0427-2015
FDA event ID
70013
Recalling firm
American Specialty Pharmacy, Plano, TX
Classification
Class II
Status
Terminated
Recall initiated
12 Dec 2014
FDA classified
26 Mar 2015
Reported
1 Apr 2015
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Particulate Matter

Timeline

12 Dec 2014Recall initiated by company
26 Mar 2015Classified by FDA+104 days
1 Apr 2015Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Particulate Matter; preservative may not have dissolved completely or precipitated out of product

Product as listed by the FDA

Hydroxocobalamin Injection Solution 1 mg/mL Inj., Rx, compounded by American Specialty Pharmacy, Plano, TX 75075 214-919-2090. NDC 99999-9994-27

Where it was distributed

TX

Texas

Questions about this recall

Why was it recalled?

Presence of Particulate Matter; preservative may not have dissolved completely or precipitated out of product

Which lots are affected?

Lot# 10082014@10

Where was it sold?

TX

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other Hydroxocobalamin recalls

All 22